SlideShare ist ein Scribd-Unternehmen logo
1 von 28
Downloaden Sie, um offline zu lesen
Dudley Tarlton
                           dudley.tarlton@undp.org
                          UNDP Europe and the CIS
                      HIV, Health and Development
Slides from Jeffrey O’Malley and Mandeep Dhaliwal
Human Rights & HIV
          Outline

• HIV and the Law
    • Why Law Matters
    • Global Commission on HIV and the Law
• Regional Context
    • Trends
    • Recommendations
    • Case study
Human Rights & HIV:
   The AIDS Paradox
“Inorder to prevent and
control the spread of HIV, we
must protect and promote the
human rights of those most
vulnerable, typically
marginalized”
Key Populations: Burdened and
linked
    One-quarter of the 3.7 million people who inject drugs
     in EECA are living with HIV

    Sex workers, drug users, men who have sex with men,
     transgender people, prisoners and migrants exist
     everywhere in the world, and are bridge populations

    HIV prevention, treatment and care services often fail to
     cover them, and are under-funded

    Social marginalisation
Expenditures for HIV Prevention
          MSM: 1.2%

 SW: 1%               IDU: 2%




                                               Other prevention
                                                services: 96%



                  Source: UNGASS 2008 Country reporting Data
Why the law matters




                                                                               Structural
                                                                               change
                                                                               (enabling
                                                                               environment)




     Source: Cost and Finance Working Group, aids2031 (across 139 countries)

                                                                                        6
Why the law matters

Critical enablers such as
the law can contribute
significantly to reducing
HIV incidence for a
relatively low cost
(Investment Framework)

The Lancet 2011; 377:2031-2041in
  (DOI:10.1016/S0140-
Global Commission on HIV and the Law




      www.hivlawcommission.org
Global Commission on HIV and the Law

“If laws are not able to
express a modern thought
that is humane, a thought
that takes into account
human rights and
eliminates repressive
policies and practices, we
will not see progress in
HIV and development.”

 Chair, Global Commission on HIV
  and the Law Fernando Henrique
                        Cardoso
100
                                                                                               Countries reporting
                                                                                               having non-
                                                                                               discrimination
                                                                                               laws/regulations
                        80                                                                     with protection for
                                                                                               this population
 Median percentage
                                                                                               Countries reporting
   of population                                                                               NOT having non-
                        60
   reached with                                                                                discrimination
  HIV prevention                                                                               laws/regulations
      services                                                                                 with protection for
                                                                                               this population
(UNGASS indicator 9)    40




                        20




                        0
                             Sex workers   Injecting drug       Men having
                               (N=42)      users (N=17)         sex with men
                                                                   (N=28)

                                                    Source: UNGASS Country Progress Reports 2008
Some successes and important lessons
   – the legal environment (laws, law enforcement and access to
   justice) has a significant impact on access to HIV prevention,
   treatment, care and support
   –the impact of punitive laws, policies, practices, stigma and
   discrimination is often most acutely felt by people living with HIV,
   men who have sex with men, transgender people, people who use
   drugs
   –punitive and discriminatory legal environments limit the capacity of
   communities and suppress uptake of essential services

On-going challenges:
   –Criminalization of transmission, exposure, MSM and TG, SW,
   people who use drugs
   –Discrimination
   – Lack of ‘healthy’ law enforcement
   –Expanding access to justice
   –Stigma, discrimination and exclusion of key pops
   –Violence – including gender based violence
   Remove all legal barriers that impede access
    to HIV and health commodities and services
    for Key Populations

   End all forms of violence and harassment
    against Key Populations
   Drug use causes harm, but criminalisation
    and punishment are inappropriate, have
    failed and exacerbate HIV

   Harm reduction – access to clean needles,
    drug substitution has proven to be effective;
    but criminal law often prevents such
    interventions
   Alter approach towards drug use from a purely
    punitive one to one that promotes health and
    treatment of users
    ◦ Immediate closure of compulsory drug detention
      centres, replaced by voluntary services for treating drug
      dependence
    ◦ Abolish national registries of drug users and mandatory
      testing and forced treatment of drug users
    ◦ Abolish jailing of users or those who possess drugs for
      personal consumption
    ◦ Review and reform, in partnership with the UN, relevant
      portions of the international narcotics conventions
Human Rights & HIV
  The regional perspective

• HIV and the Law
    • Why Law Matters
    • Global Commission on HIV and the Law
• Regional Context
    • Trends
    • Recommendations
    • Case study
Bottom Line


Eastern Europe and Central Asia is the only
region in the world where HIV prevalence
continues to increase

Only 19 percent of adults in the region
who need ARVs have access to them
•   Western Europe: Epidemic driven by MSM.
    Prevalence rate is low stable.

•   Central Europe: Epidemic is also driven by
    MSM. Prevalence rates also low.

•   Eastern Europe and Central Asia: Different
    epidemic profile. Higher prevalence.
    Epidemic driven by IDU but sexual
    transmission accounts for a growing
    proportion of new infections.
Predominant mode of transmission of
                                    newly reported HIV cases, 2009*

    Sex between men

    Heterosexual

    Injecting drug use

    Data unavailable




10 November 2010
 Hidden epidemic: HIV, MSM and transgender people in eastern   *Or most recent data
 Europe and central Asia


                                                                                 19
                                                                                 19
•   Highly concentrated


•   Stigma, discrimination and social exclusion:


•   Legal environment
Drug Policies in need of reform


63% of countries in EECA identified drug policy
as a barrier to HIV treatment




             Source: Dublin Declaration Report 2010
Trends from Europe and Central Asia:

Kyrgyzstan have moved from treating drug dependence as a criminal issue
to a health issue

Ukraine has provided a legal framework for the introduction of OST for
people who use drugs.

Moldova has adopted progressive prison laws and drug policies.

The Russian Federation has also provided social protection rights for the
children of HIV-positive parents.

Countries like Bulgaria, Romania and Slovakia, have, as a condition of EU
accession, revised national laws to better protect the rights of PLHIV and
those vulnerable to it.

Other countries, like Croatia, are also in the process of doing so.
Access to Needle/Syringe Programmes among IDU


Central Asia                Eastern Europe
33% of IDU                  7-15% of IDU
92 needles/year             9 needles/year


Central Asia                                          Eastern Europe




                     Source: International Harm Reduction Association, 2010
Best Practices from the Region:
• Promote drug demand reduction

• De-emphasize the law enforcement approach

• Use health laws to address drug dependence

• Administrative citations for simple possession/use

• Provide needles/syringes in pharmacies

• Drug users are offered the health services the need
Case study of a smart drug policy:
• Possession/personal use not criminalised initially

• Law amended to outlaw possession

• But not for small quantities for personal use

• Each case assessed in court individually

• In practice, police and prosecutors don’t prosecute simple possession


The Country?
Case study of a smart drug policy:
• Possession/personal use not criminalised initially

• Law amended to outlaw possession

• But not for small quantities for personal use

• Each case assessed in court individually

• In practice, police and prosecutors don’t prosecute simple possession


The Country?

Poland, 1985-1997
Human Rights and HIV in Eastern Europe and the CIS

Weitere ähnliche Inhalte

Ähnlich wie Human Rights and HIV in Eastern Europe and the CIS

Drug use, Treatment, Rehabilitation and HIV
Drug use, Treatment, Rehabilitation and HIVDrug use, Treatment, Rehabilitation and HIV
Drug use, Treatment, Rehabilitation and HIVHerrupribadi77
 
The UNAIDS Guidance Note on Sex Work and HIV
The UNAIDS  Guidance Note on  Sex Work and HIVThe UNAIDS  Guidance Note on  Sex Work and HIV
The UNAIDS Guidance Note on Sex Work and HIVIDS
 
Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...gnpplus
 
The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...
The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...
The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...Sketchpowder, Inc.
 
The need for better HIV data, funding and services for MSM and transgender pe...
The need for better HIV data, funding and services for MSM and transgender pe...The need for better HIV data, funding and services for MSM and transgender pe...
The need for better HIV data, funding and services for MSM and transgender pe...UNDP HIV, Health and Development Practice
 
The Global Commission on HIV and the Law & Global Fund Synergies - September ...
The Global Commission on HIV and the Law & Global Fund Synergies - September ...The Global Commission on HIV and the Law & Global Fund Synergies - September ...
The Global Commission on HIV and the Law & Global Fund Synergies - September ...UNDP HIV, Health and Development Practice
 
Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008Sonia Bezziccheri
 
AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...
AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...
AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...AIDSTAROne
 
Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013
Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013
Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013Emilie Pradichit
 
HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications Vih.org
 
Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...
Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...
Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...Yvonne Sibuea
 
HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)Mary Beth Levin
 
Access challenges for_hiv_treatment_ka_ps
Access challenges for_hiv_treatment_ka_psAccess challenges for_hiv_treatment_ka_ps
Access challenges for_hiv_treatment_ka_psclac.cab
 
HIV prevention conference
HIV prevention conferenceHIV prevention conference
HIV prevention conferenceMary Beth Levin
 
Presentation by Kenny, Trevvy
Presentation by Kenny, TrevvyPresentation by Kenny, Trevvy
Presentation by Kenny, TrevvyShazlina Sahlan
 
Prevention and treatment of HIV
Prevention and treatment of HIVPrevention and treatment of HIV
Prevention and treatment of HIVclac.cab
 

Ähnlich wie Human Rights and HIV in Eastern Europe and the CIS (20)

Drug use, Treatment, Rehabilitation and HIV
Drug use, Treatment, Rehabilitation and HIVDrug use, Treatment, Rehabilitation and HIV
Drug use, Treatment, Rehabilitation and HIV
 
The UNAIDS Guidance Note on Sex Work and HIV
The UNAIDS  Guidance Note on  Sex Work and HIVThe UNAIDS  Guidance Note on  Sex Work and HIV
The UNAIDS Guidance Note on Sex Work and HIV
 
Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...
 
The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...
The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...
The Indonesian response for the HIV/AIDS Epidemic among and from Injecting Dr...
 
The need for better HIV data, funding and services for MSM and transgender pe...
The need for better HIV data, funding and services for MSM and transgender pe...The need for better HIV data, funding and services for MSM and transgender pe...
The need for better HIV data, funding and services for MSM and transgender pe...
 
The Global Commission on HIV and the Law & Global Fund Synergies - September ...
The Global Commission on HIV and the Law & Global Fund Synergies - September ...The Global Commission on HIV and the Law & Global Fund Synergies - September ...
The Global Commission on HIV and the Law & Global Fund Synergies - September ...
 
Law and HIV: Are we there yet?
Law and HIV: Are we there yet?Law and HIV: Are we there yet?
Law and HIV: Are we there yet?
 
Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
 
Us Helping Us Final Report
Us Helping Us Final ReportUs Helping Us Final Report
Us Helping Us Final Report
 
AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...
AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...
AIDSTAR-One WHO's 2010 Recommendations for HIV Treatment: National Guideline ...
 
Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013
Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013
Commission Key Findings & Recommendations - Columbia Law School, Feb. 2013
 
Scientific Sessions 2015: Barriers to scaling up of services for msm 1
Scientific Sessions 2015: Barriers to scaling up of services for msm 1Scientific Sessions 2015: Barriers to scaling up of services for msm 1
Scientific Sessions 2015: Barriers to scaling up of services for msm 1
 
HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications
 
Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...
Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...
Regional Issues Brief : LAWS AND PRACTICES RELATING TO CRIMINALIZATION OF PEO...
 
HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)
 
Access challenges for_hiv_treatment_ka_ps
Access challenges for_hiv_treatment_ka_psAccess challenges for_hiv_treatment_ka_ps
Access challenges for_hiv_treatment_ka_ps
 
HIV prevention conference
HIV prevention conferenceHIV prevention conference
HIV prevention conference
 
Presentation by Kenny, Trevvy
Presentation by Kenny, TrevvyPresentation by Kenny, Trevvy
Presentation by Kenny, Trevvy
 
Prevention and treatment of HIV
Prevention and treatment of HIVPrevention and treatment of HIV
Prevention and treatment of HIV
 

Mehr von UNDP Eurasia

2018 DRR Financing 2.1 Andy Palmer
2018 DRR Financing 2.1 Andy Palmer2018 DRR Financing 2.1 Andy Palmer
2018 DRR Financing 2.1 Andy PalmerUNDP Eurasia
 
2018 DRR Financing 6.2 Ivan Zverzhanovski
2018 DRR Financing 6.2 Ivan Zverzhanovski2018 DRR Financing 6.2 Ivan Zverzhanovski
2018 DRR Financing 6.2 Ivan ZverzhanovskiUNDP Eurasia
 
2018 DRR Financing 6.1 Ben Slay
2018 DRR Financing 6.1 Ben Slay2018 DRR Financing 6.1 Ben Slay
2018 DRR Financing 6.1 Ben SlayUNDP Eurasia
 
2018 DRR Financing 5.8 Margaretta Ayoung
2018 DRR Financing 5.8 Margaretta Ayoung2018 DRR Financing 5.8 Margaretta Ayoung
2018 DRR Financing 5.8 Margaretta AyoungUNDP Eurasia
 
2018 DRR Financing 5.7 Jovanka Cetkovic
2018 DRR Financing 5.7 Jovanka Cetkovic2018 DRR Financing 5.7 Jovanka Cetkovic
2018 DRR Financing 5.7 Jovanka CetkovicUNDP Eurasia
 
2018 DRR Financing 5.6 Maxim Bouev
2018 DRR Financing 5.6 Maxim Bouev2018 DRR Financing 5.6 Maxim Bouev
2018 DRR Financing 5.6 Maxim BouevUNDP Eurasia
 
2018 DRR Financing 5.5 Daniel Stander
2018 DRR Financing 5.5 Daniel Stander2018 DRR Financing 5.5 Daniel Stander
2018 DRR Financing 5.5 Daniel StanderUNDP Eurasia
 
2018 DRR Financing 5.4 Kirill Ilinski
2018 DRR Financing 5.4 Kirill Ilinski2018 DRR Financing 5.4 Kirill Ilinski
2018 DRR Financing 5.4 Kirill IlinskiUNDP Eurasia
 
2018 DRR Financing 5.3 Kirill Savrassov
2018 DRR Financing 5.3 Kirill Savrassov2018 DRR Financing 5.3 Kirill Savrassov
2018 DRR Financing 5.3 Kirill SavrassovUNDP Eurasia
 
2018 DRR Financing 5.2 Clive O` Connell
2018 DRR Financing 5.2 Clive O` Connell2018 DRR Financing 5.2 Clive O` Connell
2018 DRR Financing 5.2 Clive O` ConnellUNDP Eurasia
 
2018 DRR Financing 5.1 Rhodri Lane
2018 DRR Financing 5.1 Rhodri Lane2018 DRR Financing 5.1 Rhodri Lane
2018 DRR Financing 5.1 Rhodri LaneUNDP Eurasia
 
2018 DRR Financing 4.3 Onno Heuvel
2018 DRR Financing 4.3 Onno Heuvel2018 DRR Financing 4.3 Onno Heuvel
2018 DRR Financing 4.3 Onno HeuvelUNDP Eurasia
 
2018 DRR Financing 4.2 Yusuke Taishi
2018 DRR Financing 4.2 Yusuke Taishi2018 DRR Financing 4.2 Yusuke Taishi
2018 DRR Financing 4.2 Yusuke TaishiUNDP Eurasia
 
2018 DRR Financing 4.1 Olga Buto
2018 DRR Financing 4.1 Olga Buto2018 DRR Financing 4.1 Olga Buto
2018 DRR Financing 4.1 Olga ButoUNDP Eurasia
 
2018 DRR Financing 3.4 David Simmons
2018 DRR Financing 3.4 David Simmons2018 DRR Financing 3.4 David Simmons
2018 DRR Financing 3.4 David SimmonsUNDP Eurasia
 
2018 DRR Financing 3.3 Natalie Kraus
2018 DRR Financing 3.3 Natalie Kraus2018 DRR Financing 3.3 Natalie Kraus
2018 DRR Financing 3.3 Natalie KrausUNDP Eurasia
 
2018 DRR Financing 3.2 Andy Palmer
2018 DRR Financing 3.2 Andy Palmer2018 DRR Financing 3.2 Andy Palmer
2018 DRR Financing 3.2 Andy PalmerUNDP Eurasia
 
2018 DRR Financing 3.1 Karina Whalley
2018 DRR Financing 3.1 Karina Whalley2018 DRR Financing 3.1 Karina Whalley
2018 DRR Financing 3.1 Karina WhalleyUNDP Eurasia
 
2018 DRR Financing 2.4 Rom Aviv
2018 DRR Financing 2.4 Rom Aviv2018 DRR Financing 2.4 Rom Aviv
2018 DRR Financing 2.4 Rom AvivUNDP Eurasia
 
2018 DRR Financing 2.3 Henning Ludolphs
2018 DRR Financing 2.3 Henning Ludolphs2018 DRR Financing 2.3 Henning Ludolphs
2018 DRR Financing 2.3 Henning LudolphsUNDP Eurasia
 

Mehr von UNDP Eurasia (20)

2018 DRR Financing 2.1 Andy Palmer
2018 DRR Financing 2.1 Andy Palmer2018 DRR Financing 2.1 Andy Palmer
2018 DRR Financing 2.1 Andy Palmer
 
2018 DRR Financing 6.2 Ivan Zverzhanovski
2018 DRR Financing 6.2 Ivan Zverzhanovski2018 DRR Financing 6.2 Ivan Zverzhanovski
2018 DRR Financing 6.2 Ivan Zverzhanovski
 
2018 DRR Financing 6.1 Ben Slay
2018 DRR Financing 6.1 Ben Slay2018 DRR Financing 6.1 Ben Slay
2018 DRR Financing 6.1 Ben Slay
 
2018 DRR Financing 5.8 Margaretta Ayoung
2018 DRR Financing 5.8 Margaretta Ayoung2018 DRR Financing 5.8 Margaretta Ayoung
2018 DRR Financing 5.8 Margaretta Ayoung
 
2018 DRR Financing 5.7 Jovanka Cetkovic
2018 DRR Financing 5.7 Jovanka Cetkovic2018 DRR Financing 5.7 Jovanka Cetkovic
2018 DRR Financing 5.7 Jovanka Cetkovic
 
2018 DRR Financing 5.6 Maxim Bouev
2018 DRR Financing 5.6 Maxim Bouev2018 DRR Financing 5.6 Maxim Bouev
2018 DRR Financing 5.6 Maxim Bouev
 
2018 DRR Financing 5.5 Daniel Stander
2018 DRR Financing 5.5 Daniel Stander2018 DRR Financing 5.5 Daniel Stander
2018 DRR Financing 5.5 Daniel Stander
 
2018 DRR Financing 5.4 Kirill Ilinski
2018 DRR Financing 5.4 Kirill Ilinski2018 DRR Financing 5.4 Kirill Ilinski
2018 DRR Financing 5.4 Kirill Ilinski
 
2018 DRR Financing 5.3 Kirill Savrassov
2018 DRR Financing 5.3 Kirill Savrassov2018 DRR Financing 5.3 Kirill Savrassov
2018 DRR Financing 5.3 Kirill Savrassov
 
2018 DRR Financing 5.2 Clive O` Connell
2018 DRR Financing 5.2 Clive O` Connell2018 DRR Financing 5.2 Clive O` Connell
2018 DRR Financing 5.2 Clive O` Connell
 
2018 DRR Financing 5.1 Rhodri Lane
2018 DRR Financing 5.1 Rhodri Lane2018 DRR Financing 5.1 Rhodri Lane
2018 DRR Financing 5.1 Rhodri Lane
 
2018 DRR Financing 4.3 Onno Heuvel
2018 DRR Financing 4.3 Onno Heuvel2018 DRR Financing 4.3 Onno Heuvel
2018 DRR Financing 4.3 Onno Heuvel
 
2018 DRR Financing 4.2 Yusuke Taishi
2018 DRR Financing 4.2 Yusuke Taishi2018 DRR Financing 4.2 Yusuke Taishi
2018 DRR Financing 4.2 Yusuke Taishi
 
2018 DRR Financing 4.1 Olga Buto
2018 DRR Financing 4.1 Olga Buto2018 DRR Financing 4.1 Olga Buto
2018 DRR Financing 4.1 Olga Buto
 
2018 DRR Financing 3.4 David Simmons
2018 DRR Financing 3.4 David Simmons2018 DRR Financing 3.4 David Simmons
2018 DRR Financing 3.4 David Simmons
 
2018 DRR Financing 3.3 Natalie Kraus
2018 DRR Financing 3.3 Natalie Kraus2018 DRR Financing 3.3 Natalie Kraus
2018 DRR Financing 3.3 Natalie Kraus
 
2018 DRR Financing 3.2 Andy Palmer
2018 DRR Financing 3.2 Andy Palmer2018 DRR Financing 3.2 Andy Palmer
2018 DRR Financing 3.2 Andy Palmer
 
2018 DRR Financing 3.1 Karina Whalley
2018 DRR Financing 3.1 Karina Whalley2018 DRR Financing 3.1 Karina Whalley
2018 DRR Financing 3.1 Karina Whalley
 
2018 DRR Financing 2.4 Rom Aviv
2018 DRR Financing 2.4 Rom Aviv2018 DRR Financing 2.4 Rom Aviv
2018 DRR Financing 2.4 Rom Aviv
 
2018 DRR Financing 2.3 Henning Ludolphs
2018 DRR Financing 2.3 Henning Ludolphs2018 DRR Financing 2.3 Henning Ludolphs
2018 DRR Financing 2.3 Henning Ludolphs
 

Human Rights and HIV in Eastern Europe and the CIS

  • 1. Dudley Tarlton dudley.tarlton@undp.org UNDP Europe and the CIS HIV, Health and Development Slides from Jeffrey O’Malley and Mandeep Dhaliwal
  • 2. Human Rights & HIV Outline • HIV and the Law • Why Law Matters • Global Commission on HIV and the Law • Regional Context • Trends • Recommendations • Case study
  • 3. Human Rights & HIV: The AIDS Paradox “Inorder to prevent and control the spread of HIV, we must protect and promote the human rights of those most vulnerable, typically marginalized”
  • 4. Key Populations: Burdened and linked  One-quarter of the 3.7 million people who inject drugs in EECA are living with HIV  Sex workers, drug users, men who have sex with men, transgender people, prisoners and migrants exist everywhere in the world, and are bridge populations  HIV prevention, treatment and care services often fail to cover them, and are under-funded  Social marginalisation
  • 5. Expenditures for HIV Prevention MSM: 1.2% SW: 1% IDU: 2% Other prevention services: 96% Source: UNGASS 2008 Country reporting Data
  • 6. Why the law matters Structural change (enabling environment) Source: Cost and Finance Working Group, aids2031 (across 139 countries) 6
  • 7. Why the law matters Critical enablers such as the law can contribute significantly to reducing HIV incidence for a relatively low cost (Investment Framework) The Lancet 2011; 377:2031-2041in (DOI:10.1016/S0140-
  • 8.
  • 9. Global Commission on HIV and the Law www.hivlawcommission.org
  • 10. Global Commission on HIV and the Law “If laws are not able to express a modern thought that is humane, a thought that takes into account human rights and eliminates repressive policies and practices, we will not see progress in HIV and development.” Chair, Global Commission on HIV and the Law Fernando Henrique Cardoso
  • 11. 100 Countries reporting having non- discrimination laws/regulations 80 with protection for this population Median percentage Countries reporting of population NOT having non- 60 reached with discrimination HIV prevention laws/regulations services with protection for this population (UNGASS indicator 9) 40 20 0 Sex workers Injecting drug Men having (N=42) users (N=17) sex with men (N=28) Source: UNGASS Country Progress Reports 2008
  • 12. Some successes and important lessons – the legal environment (laws, law enforcement and access to justice) has a significant impact on access to HIV prevention, treatment, care and support –the impact of punitive laws, policies, practices, stigma and discrimination is often most acutely felt by people living with HIV, men who have sex with men, transgender people, people who use drugs –punitive and discriminatory legal environments limit the capacity of communities and suppress uptake of essential services On-going challenges: –Criminalization of transmission, exposure, MSM and TG, SW, people who use drugs –Discrimination – Lack of ‘healthy’ law enforcement –Expanding access to justice –Stigma, discrimination and exclusion of key pops –Violence – including gender based violence
  • 13. Remove all legal barriers that impede access to HIV and health commodities and services for Key Populations  End all forms of violence and harassment against Key Populations
  • 14. Drug use causes harm, but criminalisation and punishment are inappropriate, have failed and exacerbate HIV  Harm reduction – access to clean needles, drug substitution has proven to be effective; but criminal law often prevents such interventions
  • 15. Alter approach towards drug use from a purely punitive one to one that promotes health and treatment of users ◦ Immediate closure of compulsory drug detention centres, replaced by voluntary services for treating drug dependence ◦ Abolish national registries of drug users and mandatory testing and forced treatment of drug users ◦ Abolish jailing of users or those who possess drugs for personal consumption ◦ Review and reform, in partnership with the UN, relevant portions of the international narcotics conventions
  • 16. Human Rights & HIV The regional perspective • HIV and the Law • Why Law Matters • Global Commission on HIV and the Law • Regional Context • Trends • Recommendations • Case study
  • 17. Bottom Line Eastern Europe and Central Asia is the only region in the world where HIV prevalence continues to increase Only 19 percent of adults in the region who need ARVs have access to them
  • 18. Western Europe: Epidemic driven by MSM. Prevalence rate is low stable. • Central Europe: Epidemic is also driven by MSM. Prevalence rates also low. • Eastern Europe and Central Asia: Different epidemic profile. Higher prevalence. Epidemic driven by IDU but sexual transmission accounts for a growing proportion of new infections.
  • 19. Predominant mode of transmission of newly reported HIV cases, 2009* Sex between men Heterosexual Injecting drug use Data unavailable 10 November 2010 Hidden epidemic: HIV, MSM and transgender people in eastern *Or most recent data Europe and central Asia 19 19
  • 20.
  • 21. Highly concentrated • Stigma, discrimination and social exclusion: • Legal environment
  • 22. Drug Policies in need of reform 63% of countries in EECA identified drug policy as a barrier to HIV treatment Source: Dublin Declaration Report 2010
  • 23. Trends from Europe and Central Asia: Kyrgyzstan have moved from treating drug dependence as a criminal issue to a health issue Ukraine has provided a legal framework for the introduction of OST for people who use drugs. Moldova has adopted progressive prison laws and drug policies. The Russian Federation has also provided social protection rights for the children of HIV-positive parents. Countries like Bulgaria, Romania and Slovakia, have, as a condition of EU accession, revised national laws to better protect the rights of PLHIV and those vulnerable to it. Other countries, like Croatia, are also in the process of doing so.
  • 24. Access to Needle/Syringe Programmes among IDU Central Asia Eastern Europe 33% of IDU 7-15% of IDU 92 needles/year 9 needles/year Central Asia Eastern Europe Source: International Harm Reduction Association, 2010
  • 25. Best Practices from the Region: • Promote drug demand reduction • De-emphasize the law enforcement approach • Use health laws to address drug dependence • Administrative citations for simple possession/use • Provide needles/syringes in pharmacies • Drug users are offered the health services the need
  • 26. Case study of a smart drug policy: • Possession/personal use not criminalised initially • Law amended to outlaw possession • But not for small quantities for personal use • Each case assessed in court individually • In practice, police and prosecutors don’t prosecute simple possession The Country?
  • 27. Case study of a smart drug policy: • Possession/personal use not criminalised initially • Law amended to outlaw possession • But not for small quantities for personal use • Each case assessed in court individually • In practice, police and prosecutors don’t prosecute simple possession The Country? Poland, 1985-1997

Hinweis der Redaktion

  1. Introduce UNDP’s work on HIV.Define the region.
  2. 30 years on we know that vulnerability to both HIV and TB infection is fueled by a wide range of human rights violations. People living with HIV around the world continue to suffer stigmatization, discrimination and violations of human rights.In the context of HIV, where human rights are protected and promoted, people are empowered: To access informationTo access non-discriminatory prevention servicesTo access life-saving treatmentTo access care and support…the mainstay of an effective AIDS response
  3. In Eastern Europe & Central Asia, an estimated ¼ of the 3.7 million people who inject drugs in the region are living with HIV Sex workers, drug users, men who have sex with men, transgender people, prisoners and migrants exist everywhere in the world, and are bridge populations (e.g. sex workers + clients, under trial prisoners and spouses, MSM who also have sex with women, sexual partners of drug users etc.) HIV prevention, treatment and care services often fail to cover them, and are under-fundedTheir social marginalisation is compounded by human rights violations and punitive approaches of the law
  4. Global estimates indicate that injecting drug use accounts for between 15-25% of HIV infections worldwide, yet only 2% of all HIV prevention funding is targeted toward people who inject drugs.Recentpolicyguidance as noted in thereports of theCommissionon AIDS in Asia and in thePacific, clearlystatesthat more of ourresourcesmustbedirectedtowhererisk and vulnerabilityisthegreatest. However, thereisstill a major gap betweenpolicy and practice.Thisisespeciallystrikingwhenone compares thistotherecentexperience of the response to H1N1 in the US, wheretheresposnewasprettyimmediate in terms of allocatingresourcestothosemost at risk – i.e.: pregnantwomen, children and healthworkers.
  5. The key question for all of us is “What can we do to change the course of the global HIV epidemic”?Are we going to pursue business as usual, allowing new infections to plateau and slowly increase again, beyond 7,400 a day?Are we going to pursue rapid scale-up of all the public health interventions at our disposal? Or are we also going to pursue structural change – changes to the overall environment that can make prevention and care more effective? Structural change – including to law and law enforcement – is not a panacea or a magic bullet. Nevertheless, it is undoubtedly one of the most effective and under-utilized tools at our disposal. - something about cost efficeinecyCurrent Trends:Coverage of key interventions continues to expand to 2015 as it has in the past few years. As a result some countries achieve universal access for some services but not others and some countries do not achieve universal access by 2015. Across all interventions coverage reaches about two-thirds of universal access targets by 2015 and then remains at those levels after 2015.
  6. The harms of human rights violations in the AIDS response are clear – harms to those who are typically marginalized by stigma, discrimination, homophobia, transphobia, violence and criminalization. These human rights violations harm all of us.The benefits of human rights protection and promotion in the HIV response are clear – protecting and promoting the rights of those most vulnerable - improving their access to essential services - benefits those who are marginalized and excluded and consequently benefits communities and countries – benefits us all.
  7. Unfortunately, there has been an epidemic recently of new legislation to criminalize HIV transmission – which of course criminalizes people who know that they are living with HIV. More than 30 countries have enacted HIV-specific laws that criminalize HIV transmission or exposure. More than two dozen countries have used non-HIV-specific laws to prosecute individuals on similar grounds. In the last few years, 16 countries in Africa have passed laws criminalizing HIV transmission and exposure. Even Germany has charged an individual for HIV transmission. The problem is that often these laws are drafted and applied too broadly and often punish behaviour that is not blameworthy. Besides, it is medically impossible to determine the exact individual source of an HIV infection.When you add this factor to the long-standing criminal and regulatory sanctions against other key populations, a very large percentage of the people we need to empower to slow the spread of HIV are instead being criminalized.
  8. In 2010 UNDP and UNAIDS convened a commission of eminent experts to investigate the ways in which the law has helped or hindered the global response to AIDS. The Commission was made up of heads of state, parliamentarians, jurists and other well known experts. The commission hosted six Regional Dialogues to hear directly from community members, policymakers and law enforcement exactly what their experiences have been with regard to HIV and the law.The dialogue for Eastern Europe and Central Asia was held last May in Moldova, and the findings from that inform much of the rest of my presentation. The final report for the Commission is due this summer and will contain country-specific recommendations.
  9. The legal environment is strongly associated with coverage and uptake of services. As you can see from the data on this slide, protection against discrimination increases HIV service coverage, which almost certainly makes HIV prevention programmes more effective. Poland, fortunately, does have laws prohibiting discrimination based on HIV status. Nonetheless coverage rates for harm reduction services – particularly methadone substitution therapy, and particularly in prisons – remain extremely low.
  10. We now have over 4 million people on life-saving treatment. In one year, from 2007 to 2008, coverage of those in need of treatment went from 33% to 42%. (In our region though, we’re stuck at around 19 percent.) Global infection rates have dropped 17% since 2001. (Though they’re still rising here.)AIDS has demanded the participation of those affected and it has demanded inclusive governance. AIDS has driven down prices of essential medicines and insisted that public health be a consideration in intellectual property law and trade agreements. Success in the AIDS response has been driven by human rights and AIDS has contributed to advancing the human rights agenda. AIDS has made economic, social and cultural rights justifiable before the courts.Despite some remarkable successes in the AIDS , a rising tide of punitive laws, polices, and practices that violate human rights is jeopardizing progress and blocking the achievement of the universal access targets and the MDGs. It is becoming increasingly clear that successes in HIV prevention, treatment and care can only be sustained and scaled up if they are underpinned by legal, regulatory and social environments that advance human rights, gender equality and social justice goals.
  11. First bullet point includes: Repeal laws that prevent access to or possession of relevant HIV prevention commodities – needles/ syringes, condoms etc. Repeal laws and reform practices of police and the judiciary which consider possession of HIV prevention commodities as evidence of intent to commit a crimeSecond bullet point includes:ending police abuse and harassment of NGO workers and membersof Key PopulationsIntroducing effective methods to lodge complaints, prosecute police personnel, and access justiceInvest in training police, public safety officials, judges
  12. Each of these recommended actions are relevant for the Eastern Europe and Central Asia region.
  13. 30 years on we know that vulnerability to both HIV and TB infection is fueled by a wide range of human rights violations. People living with HIV around the world continue to suffer stigmatization, discrimination and violations of human rights.In the context of HIV, where human rights are protected and promoted, people are empowered: To access informationTo access non-discriminatory prevention servicesTo access life-saving treatmentTo access care and support…the mainstay of an effective AIDS response
  14. We are skeptical of much of the official data on reported modes of transmission. The high levels of stigma dissuade people from reporting to their doctors exactly how they think they were infected.Worth noting here that the Czech Republic lists sex between men as the most common mode of HIV transmission – and not injecting drug use.
  15. Highly concentrated: Among IDU, sex workers, MSM and prisoners. Stigma, discrimination and social exclusion: HIV associated with behaviours that lead to social marginalisation. Legal environment: Legislative frameworks ok, but policies and practices undermine the rights of PLHIV.
  16. HIV epidemic still fueled by drug useLegislative environments generally supportiveImplementation of existing laws is uneven
  17. Policies and laws that promote drug demand reduction lead to better social and public health outcomes than those aiming for drug supply reduction. The law enforcement approach should be de-emphasized in favour of a public health approach Drug dependence issues should be included in health laws, rather than drug laws.
  18. .
  19. The amendment adopted by the Polish Parliament in December 2011 goes some way toward restoring judicial discretion on drug prosecutions. But experience tells us that whether these legislative changes are implemented in practice is a separate question.